/PRNewswire/ The Fallopian Tube Cancer Therapeutics Market size is expected to increase by USD 832.01 million, accelerating at a CAGR of 10.35% during the.
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are paired tubes that transport the egg from the ovary to the womb.
Maintenance therapy with senaparib improved progression-free survival vs placebo for patients with stage III/IV ovarian carcinoma, fallopian tube cancer, or primary peritoneal cancer who achieved a complete or partial response to first-line platinum-based chemotherapy, meeting the primary end point of the phase 3 FLAMES trial.